MedPath

Tilia Fe

(Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*)*Ferrous fumarate tablets are not USP for dissolution and assay.

Approved
Approval ID

01765e76-e656-4539-8112-8b7709597c79

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 7, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6274
Application NumberANDA076629
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate and Ethinyl Estradiol
Product Specifications
Route of AdministrationORAL
Effective DateJuly 6, 2011
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tilia Fe - FDA Drug Approval Details